Expired Tender USA ICB TOT Ref. 44027082

Study The Acute Effects Of Metreleptin In Humans Tender - 44027082

Tender notice from USA, published on 06 Jul 2020.

Executive Summary

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF has issued a Tender notice for the procurement of a Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy in the USA. This Tender notice was published on 06 Jul 2020 and is scheduled to close on 13 Jul 2020, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 44027082, while the tender notice number is and Register on the platform.

Key facts

Summary
Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy
TOT Ref. No.
44027082
Document Ref. No.
Country
USA
Notice type
Tender
Competition
ICB
Publication date
06 Jul 2020
Bid deadline
13 Jul 2020
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy
Active Contract Opportunity
Notice ID :
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NICHD
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 05, 2020 11:56 am EDT
Original Response Date: Jul 13, 2020 10:00 am EDT
Inactive Policy: Manual
Original Inactive Date: Jul 14, 2020
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: Bethesda, MD 20892-0001 USA
Description
The NIDDK would like to examine the effects of acute metreleptin treatment on metabolism in patients with lipodystrophy. The approach involves measurement, identification, and quantification of over 1, 100 different types of molecules quickly and accurately. This requires a chemical library accompanied by computer software to account for it. The library is generated by analyzing chemical standards on multiple UPLC/MS/MS and GC/MS platforms and cataloging all of the ions that are produced. Metabolon is a world leader in the field of metabolomics by pioneering and patenting the industry s leading biochemical biomarker discovery and profiling platform. It has developed the technology to quickly identify and measure the biochemicals in a biological sample through its proprietary global processing method.

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy was 13 Jul 2020. Bidding is closed.

This tender has been issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 44027082. The purchaser document reference is not provided in the notice.

Browse other tenders from USA or search by relevant keywords and CPV classification.